Group 1 - The company, Hymson Laser Technology Group Co., Ltd., will hold a half-year performance briefing on September 16, 2025, from 16:00 to 17:00 [1][2] - The briefing will be conducted in an interactive online format via the Shanghai Stock Exchange Roadshow Center [2][3] - Key personnel attending the meeting include the Chairman and General Manager, Mr. Zhao Shengyu, and other executives [2] Group 2 - Investors can submit questions for the briefing from September 9 to September 15, 2025, through the Roadshow Center website or via the company's email [3] - After the briefing, investors can access the meeting's main content and outcomes on the Roadshow Center [3]

证券代码：688559 证券简称：海目星 公告编号：2025-041 海目星激光科技集团股份有限公司 关于董事离任暨选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 海目星激光科技集团股份有限公司（以下简称"公司"）董事会于近日收到 非独立董事陆明先生的辞职申请，陆明先生因内部工作调整原因向公司申请辞去 第三届董事会非独立董事职务，根据《中华人民共和国公司法》和《公司章程》 的有关规定，其辞职报告自其书面辞职报告正式送达公司董事会之日起生效。 司第三届董事会职工代表董事，任期自本次职工代表大会审议通过之日起至公司 第三届董事会任期届满之日止。 一、董事离任情况 是否存在 是否继续在上 原定任期 未履行完 姓名 离任职务 离任时间 离任原因 市公司及其控 具体职务 到期日 毕的公开 股子公司任职 特此公告。 海目星激光科技集团股份有限公司 董事会 二零二五年八月二十八日 陆明先生辞职不会导致公司董事会成员低于法定人数，不会影响公司董事会 的正常运行，亦不会对公司的日常生产经营产生不利影响。 ...

Summary of Key Points Core Viewpoint - The company, HaiMuxing Laser Technology Group Co., Ltd., has announced a provision for impairment losses amounting to 43,395.16 million yuan for the first half of 2025, reflecting a cautious approach to accurately represent its financial status and operational results [1][2]. Group 1: Impairment Provision Overview - The company has assessed and analyzed its assets that may require impairment provisions in accordance with relevant laws and regulations, resulting in a total impairment provision of 43,395.16 million yuan for the first half of 2025 [1]. - The breakdown of the impairment provision includes 4,297.96 million yuan for credit impairment losses and 39,097.20 million yuan for asset impairment losses [1][2]. Group 2: Credit Impairment Losses - The company conducted impairment testing based on expected credit losses and individual identification methods for accounts receivable, other receivables, and notes receivable, leading to a credit impairment loss of 4,297.96 million yuan for the first half of 2025 [1][2]. Group 3: Asset Impairment Losses - The company evaluated long-term assets, including equity investments, fixed assets, construction in progress, and intangible assets, for impairment signs, resulting in a total asset impairment loss of 39,097.20 million yuan [2]. - The company also assessed inventory and contract assets for impairment, confirming the necessity of the provisions [2]. Group 4: Impact on Financial Results - The total impairment losses will reduce the company's profit before tax by 43,395.16 million yuan for the first half of 2025, aligning with the principles of prudence and reasonableness [2]. - The provision is consistent with the company's accounting policies and does not adversely affect the company's operations or shareholder interests [2]. Group 5: Audit Committee's Approval - The company's audit committee has unanimously agreed that the impairment provisions are reasonable and comply with accounting standards, ensuring that the financial statements reflect a true and fair view of the company's financial condition [2].

Core Viewpoint - The company plans to provide financial assistance of up to RMB 80 million to its subsidiary, Xingneng Maoye, to support its business development needs, with a repayment period of 36 months [1][7]. Summary by Sections Financial Assistance Overview - The financial assistance will be provided to Xingneng Maoye, a subsidiary of the company, to support its development without affecting the company's normal operations [1][7]. - The interest rate for the financial assistance will be based on the one-year Loan Prime Rate (LPR) and the company's actual bank borrowing rate [1][4]. Related Transactions - This transaction constitutes a related party transaction as it involves providing financial assistance exceeding the equity proportion held by the related parties [2][3]. - The transaction does not meet the criteria for a major asset restructuring as defined by relevant regulations [2][3]. Company and Subsidiary Relationship - The company holds a 64.2% stake in Xingneng Maoye, making it the controlling shareholder [2][4]. - Key executives of the company, including the chairman and vice president, hold shares in Xingneng Maoye, but they did not proportionally contribute to the financial assistance [2][3]. Financial Status of Xingneng Maoye - As of the latest financial data, Xingneng Maoye reported total assets of RMB 1,476.62 million and total liabilities of RMB 564.90 million [5]. - The company incurred a net loss of RMB 1,097.09 million for the fiscal year 2024 [5]. Approval Process - The financial assistance proposal was approved by the independent directors, the board of directors, and the supervisory board, with related directors abstaining from voting [8][9]. - The independent directors confirmed that the financial assistance aligns with the company's strategic goals and will not adversely affect its operations [8][9].

Core Viewpoint - The company plans to utilize part of its idle raised funds for cash management to enhance fund efficiency and returns for the company and its shareholders [1][3][6]. Summary by Sections 1. Basic Situation of Raised Funds - The company raised a total of RMB 1,019.6 million by issuing 40 million shares, with a net amount of RMB 1,010.5 million after deducting issuance costs [1][2]. 2. Investment Projects of Raised Funds - The company has allocated RMB 1,010.5 million for investment projects, including RMB 1,010.5 million for the Western Laser Intelligent Equipment Manufacturing Base Project (Phase I) [2]. 3. Cash Management of Idle Funds - The company intends to use up to RMB 150 million of idle raised funds for cash management, allowing for rolling use within this limit [3][4]. - The investment period for this cash management is valid for one year from the board's approval date [4]. 4. Types of Investments - The company plans to invest in low-risk financial products with high safety and liquidity, such as fixed deposits and structured deposits, ensuring these funds are not used for securities investment [4][5]. 5. Implementation and Disclosure - The company’s chairman is authorized to make investment decisions and sign relevant documents, with the finance department responsible for implementation [4][5]. - The company will comply with disclosure requirements as per regulations to ensure transparency [4][5]. 6. Impact on Daily Operations - The cash management plan will not affect the normal operation of the company or the execution of investment projects, while also providing potential returns for shareholders [5][6]. 7. Opinions from Supervisory Board and Sponsor - The supervisory board supports the cash management plan, stating it will enhance fund efficiency without harming the interests of the company or minority shareholders [6][7]. - The sponsor, CITIC Securities, confirms that the plan complies with relevant regulations and will not alter the intended use of raised funds [7].

Core Viewpoint - The company, HaiMuxing Laser Technology Group Co., Ltd., is committed to enhancing operational quality and returning value to shareholders through its "Quality Improvement, Efficiency Enhancement, and Return to Shareholders" action plan for 2025, focusing on innovation and market leadership in laser and automation technology [1][9]. Group 1: Business Development and Innovation - The company specializes in high-end non-standard intelligent equipment, aiming to become a global leader in laser and automation technology innovation, with a focus on lithium batteries, consumer electronics, and photovoltaic sectors [1]. - The company has developed solid-state battery equipment, becoming the first in the industry to pursue both "oxide + lithium metal anode" and "sulfide + silicon-carbon anode" technology routes [1][2]. - In the liquid lithium battery manufacturing sector, the company has made breakthroughs in laser surface treatment, drying, and roller cleaning technologies, significantly improving battery performance and reducing energy consumption [2]. - The company has achieved a 130% increase in output and a 75% reduction in labor demand through the development of an automated insulin pump production line in the medical device sector [3]. - The company has introduced the industry-first TOPCon laser thinning equipment, enhancing solar cell efficiency and securing bulk orders from clients [3]. Group 2: R&D and Technological Advancements - The company has maintained high levels of R&D investment, with 188 new patents granted in the first half of 2025, bringing the total to 1,102 patents [5]. - The company has made significant advancements in traditional laser equipment, with a 174.7% increase in orders for its high-speed laser cutting machines in the sheet metal sector [4]. - The company has collaborated with Fuzhou University to develop the first domestic wafer-level non-contact electroluminescence detection prototype, addressing key challenges in Micro LED detection technology [5]. Group 3: Corporate Governance and Investor Relations - The company is restructuring its governance by preparing to abolish the supervisory board and enhancing the roles of independent directors to improve decision-making capabilities [6]. - The company emphasizes compliance and responsibility among its key personnel, implementing regular training to enhance awareness and capabilities [6]. - The company has outlined a profit distribution plan for 2024, which includes no cash dividends or stock bonuses, focusing on long-term sustainable value for shareholders [7]. - The company has conducted various investor engagement activities, including performance briefings and investor roadshows, to strengthen communication and enhance market perception [8].

人民财讯8月27日电，海目星(688559)8月27日晚间披露半年报，2025年上半年，公司实现营业收入为 16.64亿元，同比下降30.5%；归母净利润-7.08亿元，同比由盈转亏；基本每股收益-2.91元。 ...

声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 点击查看公告原文>> 回购期限自董事会审议通过本次回购股份方案之日起12个月内。以公司目前总股本247,759,044股为基 础，按回购金额上限3600万元（含），回购价格上限46.70元/股测算，回购数量为77.0877万股，占总股 本0.3111%；按回购金额下限1800万元（含），回购价格上限46.70元/股测算，回购数量为38.5439万 股，占总股本0.1556%。具体回购数量及占比以实际回购情况为准。若公司在回购期限内有除权除息事 项，将对回购价格上限和数量相应调整。 赵盛宇在提议前6个月内除因股权激励归属事项外，无买卖公司股票情况。在回购期间暂无直接增减持 计划，若后续有相关计划，将按 ...

Core Insights - The company reported a significant decline in revenue and net profit for the first half of 2025 compared to the same period in 2024, with revenue decreasing by 30.50% to approximately 1.66 billion RMB and a net loss of approximately 708 million RMB [1][2]. Financial Performance - Total assets increased by 8.83% from the end of the previous year, reaching approximately 12.51 billion RMB [1]. - The total profit for the period was reported as a loss of approximately 712.68 million RMB, contrasting with a profit of approximately 143 million RMB in the same period last year [1]. - The net profit attributable to shareholders also showed a significant decline, with a loss of approximately 717.78 million RMB compared to a profit of approximately 128 million RMB in the previous year [1]. Shareholder Information - The total number of shareholders as of the report date was 15,852 [2]. - The company has several major shareholders, including Nanjing Shengshi Haikang Venture Capital Partnership, which holds 15.78% of the shares [3][4]. Research and Development - The report does not provide specific details on R&D expenditures as a percentage of revenue, but it is implied that R&D remains a focus area for the company [2].

每日经济新闻 每经AI快讯，海目星8月27日晚间发布公告称，海目星激光科技集团股份有限公司董事会于2025年8月 20日收到公司实际控制人、董事长兼总经理赵盛宇先生关于《提议海目星激光科技集团股份有限公司回 购公司股份的函》。赵盛宇先生提议公司以自有资金和/或自筹资金通过上海证券交易所交易系统以集 中竞价交易方式回购公司已发行的部分人民币普通股（A股）股票。本次回购的资金总额不低于人民币 1800万元（含），不超过人民币3600万元（含）。 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经头条（nbdtoutiao）——能给主人"打电话"的宠物智能手机也来了！宠物产业3000亿元市场大爆 发，行业上市公司"涨"声一片 （记者 张喜威） ...